Advertisement
Advertisement

MD

MD logo

Pediatrix Medical Group, Inc.

27.08
USD
Sponsored
+0.57
+2.15%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

27.05

-0.02
-0.09%

MD Earnings Reports

Positive Surprise Ratio

MD beat 18 of 42 last estimates.

43%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$506.87M
/
$0.68
Implied change from Q2 26 (Revenue/ EPS)
+3.91%
/
+7.94%
Implied change from Q3 25 (Revenue/ EPS)
+2.84%
/
+1.49%

Pediatrix Medical Group, Inc. earnings per share and revenue

On Aug 04, 2026, MD reported earnings of 0.63 USD per share (EPS) for Q2 26, beating the estimate of 0.60 USD, resulting in a 3.40% surprise. Revenue reached 487.78 million, compared to an expected 492.80 million, with a -1.02% difference. The market reacted with a -5.87% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.68 USD, with revenue projected to reach 506.87 million USD, implying an increase of 7.94% EPS, and increase of 3.91% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Sotera Health Company Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.24
Actual
$0.26
Surprise
+7.62%
logo
Establishment Labs Holdings Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.34
Actual
-$0.39
Surprise
-13.67%
logo
Progyny, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.34
Actual
$0.55
Surprise
+60.96%
logo
Natera, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.50
Actual
-$0.47
Surprise
+6.67%
logo
Viatris Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.61
Actual
$0.69
Surprise
+12.58%
logo
Omada Health, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.01
Actual
$0.15
Surprise
+1,020.25%
logo
Nutex Health Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$5.05
Actual
$9.58
Surprise
+89.59%
logo
CryoPort, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.20
Surprise
-1.16%
logo
Shoulder Innovations, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.46
Surprise
+2.85%
logo
Embecta Corp. Common Stock
Report Date
Aug 07, 2026 For Q3 26
Estimate
$0.27
Actual
$0.56
Surprise
+107.18%
FAQ
For Q2 2026, Pediatrix Medical Group, Inc. reported EPS of $0.63, beating estimates by 3.4%, and revenue of $487.78M, -1.02% below expectations.
The stock price moved down -5.87%, changed from $26.25 before the earnings release to $24.71 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 9 analysts, Pediatrix Medical Group, Inc. is expected to report EPS of $0.68 and revenue of $506.87M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement